Ensuring robust QC processes during manufacturing and scaling
30 Apr 2026
Quality Control
- How can QC strategies evolve to support increasing sequence diversity and chemical complexity in oligonucleotide and peptide pipelines
- What analytical gaps emerge during scale-up that are not apparent at early development stages
- How should critical quality attributes be defined and controlled as processes transition from development to GMP manufacture
- What challenges exist in maintaining method robustness across multiple sites or manufacturing partners
- How can QC teams proactively support tech transfer and reduce risk during late-stage scale-up